Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHA2 | P29317 | 3/20 | 0.67 |
| ▸ | GPBAR1 | Q8TDU6 | 9/20 | 0.64 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.58 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.58 |
| ▸ | EFNA1 | P20827 | 1/20 | 0.58 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.58 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.58 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.58 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.58 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.58 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.58 |
| ▸ | ABCC4 | O15439 | 3/20 | 0.57 |
| ▸ | VDR | P11473 | 2/20 | 0.57 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4777980 | 1.00 | EPHA2 (0.67) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL18045259 | 1.00 | EPHA2 (0.67) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| Water SCHEMBL278724 | 0.99 | EPHA2 (0.66) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| Water SCHEMBL8333417 | 0.99 | EPHA2 (0.66) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL55596 | 0.93 | EPHA2 (0.68) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL3789015 | 0.92 | EPHA2 (0.65) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| Sulfuric Acid SCHEMBL2285700 | 0.92 | EPHA2 (0.67) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL905493 | 0.91 | EPHA2 (0.65) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL6027325 | 0.90 | EPHA2 (0.66) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| Sulfuric Acid SCHEMBL5587293 | 0.90 | EPHA2 (0.68) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 12910 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139329-A1 | METHOD TO CHARACTERIZE NUCLEIC ACID | ICHORtec GmbH (DE) | 2026-05-21 | — | — | US | claimed |
| EP-4189393-B1 | RELIABLE AND SCALABLE METHODS OF DETECTION AND PLATFORM FOR CONSUMER MEDICAL DEVICES | SIMPLE HEALTHKIT INC (US) | 2026-04-15 | — | — | EP | claimed |
| US-20260070942-A1 | REUSE OF INTEIN-BOUND RESINS FOR PROTEIN PURIFICATION | MERCK PATENT GMBH (DE) | 2026-03-12 | — | — | US | claimed |
| US-12570691-B2 | Purification of chimeric FVIII molecules | BIOVERATIV THERAPEUTICS INC. (US) | 2026-03-10 | — | — | US | claimed |
| EP-4686762-A1 | A METHOD TO CHARACTERIZE NUCLEIC ACID | ICHORtec GmbH (DE) | 2026-02-04 | — | — | EP | claimed |
| US-20260028664-A1 | METHOD TO CHARACTERIZE NUCLEIC ACID | ICHORtec GmbH (DE) | 2026-01-29 | — | — | US | claimed |
| US-20250388896-A1 | COMPOSITION AND METHODS FOR TRANSGENE INSERTION | CELYNTRA THERAPEUTICS SA (BE) | 2025-12-25 | — | — | US | claimed |
| US-12503488-B2 | Reuse of intein-bound resins for protein purification | MERCK PATENT GMBH (DE) | 2025-12-23 | — | — | US | claimed |
| US-12487527-B2 | Photoresist developer and method of developing photoresist | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2025-12-02 | — | — | US | claimed |
| US-20250362598-A1 | PHOTORESIST DEVELOPER AND METHOD OF DEVELOPING PHOTORESIST | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2025-11-27 | — | — | US | claimed |
| US-4921838-A | Angiogenic and blood perfusion inducing properties of amphiphilic compounds | TRUSTEES OF BOSTON UNIVERSITY (US) | 1990-05-01 | — | — | US | claimed |
| US-4845036-A | Process for isolation of the B oligomer of pertussis toxin | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1989-07-04 | — | — | US | claimed |
| EP-0308239-A2 | Method for reducing bacterial endotoxin contamination in solutions of macromolecules | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-03-22 | — | — | EP | claimed |
| US-4808314-A | MIXING WITH SURFACTANT, ABSORPTION, SEPARATION | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-02-28 | — | — | US | claimed |
| EP-0286367-A2 | Stabilization of beta-galactosidase peptide fragments | MICROGENICS CORPORATION (a Delaware corporation) (US) | 1988-10-12 | — | — | EP | claimed |
| EP-0260277-A1 | METHOD FOR THE EXTRACTION OF A VITAMIN-K-DEPENDENT CARBOXYLASE COMPLEX AND THE USE THEREOF | RIJKSUNIVERSITEIT LIMBURG (NL) | 1988-03-23 | — | — | EP | claimed |
| WO-1987004719-A1 | METHOD FOR THE EXTRACTION OF A VITAMIN-K-DEPENDENT CARBOXYLASE COMPLEX AND THE USE THEREOF | RIJKSUNIVERSITEIT LIMBURG (NL) | 1987-08-13 | — | — | WO | claimed |
| EP-0046523-B1 | NONDENATURING ZWITTERIONIC DETERGENTS FOR MEMBRANE BIOCHEMISTRY | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1984-07-25 | — | — | EP | claimed |
| US-4372888-A | Nondenaturing zwitterionic detergents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 1983-02-08 | — | — | US | claimed |
| EP-0046523-A1 | Nondenaturing zwitterionic detergents for membrane biochemistry | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1982-03-03 | — | — | EP | claimed |